Chemotherapy for Bladder Cancer

Chemotherapy for bladder cancer involves the use of certain drugs to destroy cancerous cells by impairing their ability to grow and divide. A typical chemo regimen consists of several cycles during which a patient may receive a single drug or a combination of several drugs at the same time. Some options include mitomycin, thiotepa, doxorubicin, gemcitabine, valrubicin, methotrexate, vinblastine, doxorubicin and cisplatin. After each cycle, a patient has several days without treatment to allow his or her body to recover.

Bladder cancer occurs when abnormal cells develop in the tissues of the bladder, a hollow, muscular organ in the lower abdomen that stores urine before it is expelled through the urethra. In most cases, these changes begin in the lining of the bladder (urothelium). Over time, the abnormal cells can multiply and form tumors, which may invade nearby tissues or spread to lymph nodes and other parts of the body. Common symptoms include pelvic discomfort, blood in the urine and frequent or painful urination.

In the United States, bladder cancer is relatively common, particularly among older adults. According to the American Cancer Society, tens of thousands of new cases are diagnosed each year, with more men affected than women. Risk factors include smoking, long-term exposure to certain chemicals and chronic bladder inflammation.

Treatment for bladder cancer can vary depending on the stage and aggressiveness of the tumor. Options may include surgery, immunotherapy, targeted therapy, radiation therapy and chemotherapy. Chemotherapy plays a key role in many treatment plans, especially for more advanced and invasive tumors.

With an ever-deepening understanding of bladder cancer and more and more effective treatment options, we will soon be able to offer patients dynamic, personalized treatment courses to help keep their bladders, while keeping the disease at bay.

Roger Li, MD

What is chemotherapy, and how does it work?

Chemotherapy is a drug-based cancer treatment that works throughout the entire body. These potent medications travel through the bloodstream to locate and destroy rapidly dividing cells or prevent them from growing. Due to its systemic effect, chemotherapy can target metastatic cancer that has spread beyond the bladder.

Because cancer cells tend to grow and divide more rapidly than most normal cells, they are especially sensitive to chemotherapy. However, certain healthy cells, including those in the bone marrow, digestive tract and hair follicles, also divide quickly and can be affected by the treatment. As a result, chemotherapy may cause side effects.

For bladder cancer, chemotherapy is often given as a combination of drugs for enhanced effectiveness. Common regimens include cisplatin, gemcitabine, carboplatin and/or paclitaxel, depending on the patient’s specific condition and treatment goals.

What are the goals of chemotherapy for bladder cancer?

Chemotherapy may be administered at several points during bladder cancer treatment. Depending on the stage of the tumor and the overall care plan, it may be used to:

• Shrink a tumor before surgery to increase the likelihood of successful removal
• Destroy microscopic cancer cells that may remain after surgery to help reduce the risk of recurrence
• Treat cancer that has spread beyond the bladder
• Slow tumor growth if surgery is not an option
• Relieve symptoms caused by advanced cancer

Each bladder cancer treatment plan is highly individualized. If chemotherapy is recommended, the healthcare team will clearly explain its intended purpose.

How is chemotherapy for bladder cancer administered?

Chemotherapy for bladder cancer is most commonly delivered through an intravenous (IV) infusion into a vein. In some cases, a port or central line may be placed to make repeated treatments more comfortable and efficient.

Treatment is typically given in cycles. Each cycle includes an active treatment period followed by a rest period to allow the body time to recover. The chemotherapy schedule and the number of cycles can vary depending on the specific drugs used and how well the patient tolerates therapy.

What is intravesical chemotherapy for bladder cancer?

Though rarely used as a first-line treatment for bladder cancer, intravesical therapy may be an option for certain cases of nonmuscle invasive bladder cancer (NMIBC) that is confined to the lining of the bladder and has not spread to deeper tissues. During intravesical therapy, liquid-form chemotherapy or immunotherapy drugs are fed directly into the bladder through a soft catheter. This localized approach can maximize treatment effectiveness while minimizing side effects, mainly because the drugs do not have to travel through other areas of the body to reach the bladder. However, the patient may notice bladder irritation, burning sensations or blood in urine following treatment.

Chemotherapy drugs that may be delivered to the bladder through intravesical therapy include:

• Gemcitabine (Gemzar®) – An antimetabolite that disrupts the ability of cancer cells to divide by attacking certain substances within the cells during specific phases of the division process
• Docetaxel (Taxotere®) – A plant-derived, antimicrotubule agent that hinders the ability of cancer cells to replicate themselves by interfering with microtubule structures inside the cells

Typically, gemcitabine is administered first, followed immediately by docetaxel. This regimen might be considered for a patient who does not respond well to bacillus Calmette-Guerin (BCG) treatment, a more common type of intravesical therapy that uses immunotherapy drugs to disrupt the processes that fuel bladder cancer growth.

Bladder Cancer Outcomes

The primary aim of cancer treatment is to attain the best possible outcome with minimal side effects, ensuring the highest quality of life for the patient. On average, Moffitt's bladder cancer treatment survival rates are 2.5 times higher than the national average.

Our Outcomes

What to expect before, during and after chemotherapy for bladder cancer

Before starting treatment, the patient will undergo a thorough evaluation to confirm that chemotherapy is appropriate. Typically, this will include a series of imaging scans, blood tests and discussions about medical history and current medications.

The patient will then meet with a medical oncologist to review the treatment plan and discuss potential side effects. In some cases, additional evaluations, such as kidney or heart function testing, may be recommended depending on the drugs prescribed.

During chemotherapy for bladder cancer

Chemotherapy is usually administered in an outpatient infusion center. On treatment days, the patient can expect:

• A review of symptoms and side effects
• Vital sign monitoring
• Blood testing, if needed
• Medications to help prevent nausea or allergic reactions
• IV infusion of the chemotherapy drugs
• Ongoing monitoring during treatment

Each infusion session may last up to several hours, depending on the treatment plan. The patient may want to bring items that can help them stay comfortable, such as a sweater, book or laptop.

After chemotherapy for bladder cancer

Between chemotherapy cycles, the patient’s body will work hard to recover from treatment. During that time, the patient will typically be advised to:

• Stay well hydrated
• Eat nutrient-rich foods
• Remain physically active as tolerated
• Take prescribed medications for symptom control
• Attend follow-up appointments and lab checks

Any new or worsening symptoms, such as fever, severe fatigue or shortness of breath, should be reported promptly to the healthcare team.

What are the possible side effects of chemotherapy for bladder cancer?

Because chemotherapy affects all rapidly dividing cells—both cancerous and healthy—it may cause side effects, which can vary based on the drugs used and the patient’s overall health.

Common side effects of chemotherapy for bladder cancer

Most patients experience some side effects during chemotherapy, which may include:

• Fatigue
• Nausea or vomiting
• Loss of appetite
• Hair thinning or loss
• Increased risk of infection due to low white blood cell counts
• Anemia, which may cause weakness or shortness of breath
• Easy bruising or bleeding
• Mouth sores
• Diarrhea or constipation
• Nerve-related symptoms, such as numbness or tingling

Most side effects are temporary and can be managed with supportive care.

Possible long-term and late-onset side effects of chemotherapy for bladder cancer

Some chemotherapy drugs, such as cisplatin and other platinum-based agents, may cause lasting or delayed side effects, including:

• Persistent nerve damage
• Changes in kidney function
• Hearing loss, especially with certain platinum-based drugs
• Fertility challenges
• Heart function changes (rare)
• A small risk of developing a secondary cancer later in life

The healthcare team will closely monitor the patient both during and after treatment to help mitigate these risks.

How to manage daily life during chemotherapy for bladder cancer

Maintaining overall well-being is an important part of cancer care. During chemotherapy, the patient can support their health by:

• Eating a balanced diet with adequate protein
• Drinking water and other fluids regularly
• Engaging in light physical activity
• Practicing good hygiene to reduce infection risk
• Taking medications exactly as prescribed
• Attending all follow-up visits

Emotional support is also important. Counseling sessions, support groups and other resources can help the patient navigate the physical and emotional challenges of treatment.

Benefit from world-class care at Moffitt Cancer Center

Bladder cancer treatment can be complex, and specialized care can make a meaningful difference. At Moffitt, our patients receive coordinated care from a multispecialty team with focused expertise in urologic oncology.

As a National Cancer Institute (NCI)-designated cancer center, Moffitt is recognized for excellence in research, education and patient care. This distinction reflects our commitment to continually advancing treatment options and providing our patients with access to innovative therapies and clinical trials.

Chemotherapy for bladder cancer is available at all Moffitt locations, and we do not require referrals. If you would like more information, you can request an appointment with a specialist in our comprehensive Urologic Oncology Program by calling 1-888-663-3488 or submitting a new patient registration form online.